Marketresearchnews

Thursday, 3 September 2020

Global Picture Archiving and Communications Systems Market 2019 Analysis By Manufacturers, Latest Trends, Competitive Landscape And Strategies

An expert on premium research reports, Market Research Future has added a report titled "Global Picture Archiving and Communications Systems Market 2023" to its offering. The report provides an in-depth analysis of regional data and an accurate projection of the market size and share of the Top 10 market players across the globe.

A picture archiving and communication system (PACS) is an imaging technology providing economical and convenient storage as well as access to images. The global picture archiving and communications systems market is expected to gain an upward trajectory owing to explosive adoption of information technology in the healthcare sector.

According to Market Research Future (MRFR), the global picture archiving and communications systems market is expected to register a CAGR of over 4.43% over the assessment period (2016-2023). The attractive advantages of the picture archiving and communications systems such as elimination of manual documentation, error free archiving, digital transmission of data and the greater efficiency and ease associated with the process is driving a large demand.

Also Read : h ttps://www.medgadget.com/2019/12/technology-poised-to-transform-the-global-picture-archiving-and-communications-systems-market-mrfr-reveals-insights-for-2016-2023.html

The influx of information technology and the ubiquitous availability and adoption of smart devices, emerging web technology, and others is resulting in timely and efficient access to data. Elimination of physical barriers owing to centralization of data is also contributing towards the market growth.

The development of universal image storage and transfer standard for PACS coupled with flexibility to incorporate other standard formats such as PDF is resulting in faster adoption of PACS. The expanding adoption of imaging technologies such as computed tomography (CT) and magnetic resonance imaging (MRI) in the hospitals are other drivers of the market.

Additional factors that are fostering the market demand include the dramatically rising end-users such as hospitals and the increasing incidence of diseases.

Picture Archiving and Communications Systems Market – Segments

The report is segmented into six dynamics to widen the scope of understanding,

By Type : Oncology PACS, Cardiology PACS, Dental PACS, Orthopaedics PACS, among others.

By Components : Hardware (Access Devices, Peripherals, Servers, Storage Devices, and Networking Devices), Software, Services (Consulting, Implementation Services, Post-Sales and Maintenance Services, and Training Services), among others.

By Imaging Type : Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Nuclear Imaging, X-Ray, Ultrasound, among others.

By Delivery Mode : Cloud-Based (Saas) Delivery Mode, Web-Hosted (On-Demand) Delivery Mode, And On-Premise Mode, among others.

By End-use : Hospitals And Clinics, Healthcare Centers, Imaging Centers, Diagnostic Centers, Clinical Research Institutions, among others.

By Regions : North America, Europe, Asia Pacific, and the Rest-of-the-World.

Global Picture Archiving and Communications Systems Market – Regional Analysis

North America dominates the global picture archiving and communications systems market owing to rapid adoption of technology, presence of large hospitals and the consolidation of healthcare sectors resulting in increase in purchasing power.

The entry of technology companies in the medical devices sector is also boosting the market growth. Moreover, the established healthcare sectors and high healthcare expenditures is driving a substantial demand for the growth of the market.

Europe accounts for another large share of the picture archiving and communications systems market owing to large healthcare expenditure and the proliferating information technology and pharmaceutical industry in the region. The presence of large players in the region is providing a boost to the market growth.

The Asia Pacific picture archiving and communications systems market is expected to be in a flux and represents a bimodal nature. Japan, Australia and South Korea are leading the Asia Pacific market. However, China and India are expected to drive a momentous growth owing to their economic development.

Picture Archiving and Communications Systems Market – Competitive Landscape

The picture archiving and communications systems market is dominated by handful of large firms resulting in a pricing premium on the products. The industry is intensive in terms of intellectual property and technology which makes market entry a challenge for small players.

Manufacturers rely on collaboration and partnerships with other players to innovate new products and to cut down the development costs and time. Manufacturers of picture archiving and communications systems use a variety of distributions channels and are increasingly engaging the social media to generate inbound leads.

Major Players:

Players leading the global picture archiving and communications systems market include Siemens Healthineers, Advanced Data Systems, Allscripts Healthcare Solutions, Inc., Telediagnostics Services Pvt. Ltd.,Konica Minolta Healthcare Americas Inc., Alta Vista Teleradiology, Avreo, Inc., Radiology Imaging Solutions, Scimage, Inc., Brit Systems, Comarch SA, Cybernet Medical Corporation, Virtual Radiology (vRAD),GE Healthcare, INFINITT Healthcare, McKesson Corporation,Inc., ONRAD, Inc., Pacshealth, LLC, FujiFilm Medical Systems, Perfect Imaging, LLC, RamSoft, Inc., Global Diagnostics, Sectra Imtec AB, Sectra Imtec AB, Singular Medical Technologies, StatRad, LLC, Agfa-Gevaert N.V., Argus Radiology, Telerad Tech Private Limited, among others.

Industry/ Innovation/ Related News:

Sep 11 2018 —- Mercy Technology Services, launched its latest picture archiving communication system (PACS) imaging solution, as a Software as a Service system. The system has an automated workflow orchestrator which auto-coordinates the physicians worklist through speech recognition and reporting technology adopted from Nuance. Mercy has already adopted the system in its care facilities. The system claims to increase report turnaround time by up to 50 percent. The PACS system is an addition to Mercy Technology Servicescloud solution, launched earlier in partnership with VMware.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/picture-archiving-communications-systems-market-5833

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

The Autoimmune Disease Treatment Market World Leading Key Players Revenue, Share, Analysis And Estimation Till 2023

This study covers the market dynamics and trends in major countries that are expected to influence the current market scenario and future status of the Global Autoimmune Disease Treatment Market over the forecast period.

Market Research Future (MRFR)’s latest assessment reveals that the global autoimmune disease treatment market to thrive at 11.2% CAGR, analysis by Disease Type, Diagnosis, Therapeutic Products and Distribution Channel | Global Forecast to 2023

Autoimmune diseases are maladies in which the immune system of the body attacks the host. There are more than 80 different types of autoimmune diseases, out of which the common ones include rheumatoid arthritis, inflammatory bowel disease (IBD), multiple sclerosis, and others. The global autoimmune disease treatment market report by Market Research Future (MRFR) apprises readers of the pertinent drivers and challenges engulfing the market from 2017 to 2023.

Also Read : https://www.medgadget.com/2019/10/autoimmune-disease-treatment-market-2019-global-trends-market-share-industry-size-growth-sales-opportunities-and-market-forecast-to-2023.html

Market Overview

High prevalence of autoimmune disorders is one of the primary drivers of the market. This is supported by the survey by the National Institute of Health (NIH) which pegs the number of Americans suffering from autoimmune diseases at 23.5 million. The growing public awareness levels as well as the large efforts taken by government healthcare organizations for curbing the menace of these diseases can bode well for the market.

The centralization of patient response to novel drugs and treatments on a common database is likely to expedite the progress of autoimmune drugs exponentially. Technological advances, rising prevalence of comorbidities, rise of regulatory frameworks, and rise of government supported networks are other growth drivers of the market.

But presence of unbranded drugs, side-effects of medications, and high treatment costs are challenges faced by the global autoimmune disease market.

Segmentation

The global autoimmune disease treatment market is segmented on the basis of disease type, diagnosis, therapeutic product, and distribution channel.

By disease type, the market is segmented into systemic and localized. Systemic is further segmented into psoriasis, lupus, rheumatoid arthritis, and others. Localized, on the other hand, is segmented into diabetes, inflammatory bowel disease, and others.

By diagnosis, the autoimmune disease treatment market is segmented into multiplex immunoassay, agglutination, dot blot, line blot, ELISA, double immune diffusion, Western blotting, and others.

By therapeutic product, it is segmented into drugs and therapeutic & monitoring equipment. Corticosteroids, immunosuppressants, biologics, anti-inflammatory drugs, and non-steroidal anti-inflammatory drugs are segments subsumed within the drugs segment.

By distribution channel, it is segmented into pharmacies, drug stores, hospitals & clinics, diagnostic centers, and others.

Regional Analysis

The Middle East & Africa (MEA), Europe, Asia Pacific (APAC), and the Americas are regions taken into consideration during the compilation of the global autoimmune disease treatment market report.

The Americas are touted to dominate in the leading position during the forecast period due to a large healthcare expenditure and increase in the cases of autoimmune diseases. Introduction of favorable healthcare policies such as the Affordable Care Act and efforts by the American Autoimmune Related Diseases Association (AARDA) are likely to culminate in high dividends for the autoimmune disease treatment market from the region.

Europe is the second largest region with the biggest potential for the global market. Factors such as healthcare policies, introduction of autoimmune diagnostic techniques, and allocation of sufficient funds by governments can drive the regional demand.

The APAC region is expected to exhibit a robust growth rate during the forecast period due to the healthcare budget being elevated in several countries. The large patient pool as well as the rising number of medicines being developed at pharmaceutical companies can contribute to the market revenue.

The MEA autoimmune disease treatment market possesses the lowest potential for returns due to poor healthcare infrastructure and lack of technical experts.

Competition Outlook

Johnson & Johnson Inc., Danaher, Siemens, Bio-Rad, Merck & Co. Inc., Genentech Inc., Biogen Idec Inc., F. Hoffmann-La Roche AG, Eli Lilly and Company, Thermo Fisher Scientific, Abbott Laboratories, HYCOR Biomedical, Squibb Company, Bayer Schering Pharma AG, Elan Corporation Plc, GlaxoSmithKline Plc, Chugai Pharmaceutical Co. Ltd., Amgen Inc., and others are major players in the global autoimmune disease treatment market.

Industry News

Clinical trials are being conducted for expediting the drug development for various autoimmune disorders. To this effect, Michigan Medicine, a branch of the University of Michigan was granted close to USD 10.2 million by the Autoimmunity Centers of Excellence for exploring the potential of autoimmune disease treatments. Drugs to be tested include tofacitinib and elotuzumab.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/autoimmune-disease-treatment-market-5586

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Acoustic Neuroma Market Cagr Growth Expected To Be Linear To The Skyrocketing Rise ! Predicted By 2023

Market Research Future with their unique quality of simplifying the market research study, announces a deep study report on “Acoustic Neuroma Market Research Report - Forecast to 2023” Gives industry size, top players and worldwide demand

Acoustic neuroma is a non-cancerous (benign) tumor that grows on the vestibulocochlear nerve, which connects the brain and inner ear. It is a non-dangerous condition until its expansion presses other vital brain parts. On observing the current trends, the global acoustic neuroma market is projected to touch a 08 % annual growth mark during the survey periods.

Also Read : https://www.marketwatch.com/press-release/acoustic-neuroma-market-will-increase-at-76-cagr-by-2023-covid-19-impact-analysis-industry-size-share-growth-opportunities-top-companies-merger-regional-outlook-2020-06-17?mod=mw_quote_news

This disease grows slowly and may take several years to develop with symptoms like dizziness, degrading hearing power, loss of balance and others but does not spread to the other body parts. Acoustic neuroma is a very rare disease and is more vibrant among women and middle-aged groups rather than young generations.

Global Acoustic Neuroma Market segments

The global acoustic neuroma market is segmented into four parts, which are:

Types: Acoustic neuroma is of two kinds, namely unilateral vestibular schwannomas and bilateral vestibular schwannomas.

Treatments: Middle fossa, surgical removal, radiation therapy, single-fraction stereotactic radiosurgery, and other types of diagnoses are there.

Drugs: Painkillers, corticosteroids, anticonvulsants, and osmotic diuretics drugs are present for acoustic neuroma.

End-Users: Major healthcare facilities like hospitals, clinics, research institutes, and others are the major end-users.

Acoustic Neuroma Market Regional Summary

America, Europe, Asia Pacific, and The Middle East & Africa are the major regions observed for the global acoustic neuroma market.

The American region is the current market leader with The North American region, the largest shareholder. The emphasis towards disease eradication, well-established healthcare facilities, presence of key market leaders and other factors are responsible for the seamless growth in this market. The European region is the second-largest market due to increasing awareness about new diseases, increasing research & development programs and other factors.

The Asia Pacific region is the next market in this tally and will emerge as the fastest-growing market. Increasing patient counts, large population covers, improving healthcare facilities, research & development programs, and other factors are driving the market towards healthier futures.

The rest of the regions are growing at sluggish rates due to the least awareness and struggling economic structures.

Acoustic Neuroma Market Key Players

Some of key the players in the global acoustic neuroma market are GE Healthcare (U.S.), Siemens Healthcare(U.S.), Philips Healthcare (U.S.), Shimadzu Corporation (Japan), Toshiba Medical Systems Corporation (Japan), F. Hoffmann-La Roche Ag, Merck & Co., Inc., Novartis AG, Pfizer Inc., and others

Acoustic Neuroma Industry News

The global acoustic neuroma market is still in the growing stages and is holding a small share in the market due to less occurrence of this disease. In future aspects, the increasing populations and disease counts will accelerate the market, but costly treatments are hindering the market’s growth rates. The companies are trying to search for cheaper treatment procedures and spreading awareness about this disease. The American region, with The North American region major shareholder, is the current market leader and will stay at the top during the survey period. In contrast, the Asia Pacific region will emerge as the fastest-growing market.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/acoustic-neuroma-market-5107

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Sepsis Diagnostics Market Scenario, Leading Players, Segments Analysis and Growth by Forecast to 2023

Market Research Future adds the “Sepsis Diagnostics Market Research Report - Forecast to 2023” report to their unique collection.

Sepsis Diagnostics Market Overview

Global sepsis diagnostics market is expected to exhibit a strong 8% CAGR over the forecast period from 2016 to 2022, according to the latest research report from Market Research Future (MRFR). The global sepsis diagnostics market is expected to reach a valuation of USD 710 million by the end of the forecast period. The research report profiles the global sepsis diagnostics market in great detail and provides readers with a comprehensive overview of the market. The market’s historical growth trajectory, present conditions, and future growth prospects are studied in the report. The report provides a comprehensive overview of the market’s historical growth trajectory by detailing the historical stats regarding the market. Future projections are based on the detailed historical stats offered in the report.

Also Read : https://www.medgadget.com/2020/07/sepsis-diagnostics-market-to-witness-steady-growth-at-8-cagr-by-2022-covid-19-impact-analysis-global-industry-size-swot-analysis-development-pipeline-business-growth-top-company-profile.html

Based on this platform, future projections for the sepsis diagnostics market’s growth trajectory over the forecast period are provided in the report. The report also profiles the leading players in the global sepsis diagnostics market and gives readers a comprehensive analysis of the leading players in the global sepsis diagnostics market. The report also profiles the major drivers and restraints affecting the global sepsis diagnostics market. The factors making the market tick and those holding the market back are studied in detail in the report. The impact of the COVID-19 pandemic on the sepsis diagnostics market is also assessed in the report.

Sepsis diagnostics can be used to diagnose severe sepsis as well as septic shock, which differ slightly in symptoms. Severe sepsis can cause an organ to fail, whereas septic shock is manifested through various symptoms, including low blood pressure. The rising prevalence of sepsis is the primary driver for the global sepsis diagnostics market. Sepsis is a life-threatening complication of the body’s own immune system hurting the body’s own organs or tissues. It can be caused by a weakened immune system, chronic disease, cancer, or kidney or liver diseases.

The increasing prevalence of hospital-acquired sepsis is also a major driver for the global sepsis diagnostics market. This has led to a growing demand for quick diagnostics of sepsis. This is likely to remain a major driver for the global sepsis diagnostics market over the forecast period.

Sepsis Diagnostics Market Competitive Leaderboard:

Leading players in the global sepsis diagnostics market include Sandstone Diagnostics Inc., Cube Dx GmbH, Axis-Shield Diagnostics Ltd., Becton Dickinson and Company, T2 Biosystems Inc., Immunexpress, EKF Diagnostics, and bioMerieux Inc. Technological innovation in molecular diagnostic technologies is likely to remain a major target for players in the global sepsis diagnostics market over the forecast period.

Sepsis Diagnostics Market Segmentation:

The global sepsis diagnostics market is segmented on the basis of technology, product, end use, and region.

By technology, the global sepsis diagnostics market is segmented into molecular diagnostics, biomarkers, immunoassays, and others. The molecular diagnostics segment holds the largest share in the global sepsis diagnostics market and is likely to remain the leading revenue generator over the forecast period. Molecular diagnostics are highly effective diagnosing sepsis. However, the slowness of molecular diagnostics processes is likely to count against them in the final reckoning over the coming years. Alternative technologies are likely to be developed in the coming years in order to counter the slow nature of molecular diagnostics. The biomarkers segment also accounts for a significant share in the global sepsis diagnostics market.

On the basis of product type, the global sepsis diagnostics market is segmented into kits, instruments, blood culture media, and others. The kits segment holds a major share in the global sepsis diagnostics market.

On the basis of end user, the global sepsis diagnostics market is segmented into pathology laboratories, specialty clinics, hospitals, diagnostic centers, and others.

Sepsis Diagnostics Market Regional Analysis:

North America is the leading regional market for sepsis diagnostics, followed by Europe. The presence of leading players in these two regions is likely to remain a major driver for the sepsis diagnostics market in these regions over the forecast period.

Table Of Contents

1 Introduction

1.1 Definition

1.2 Scope Of Study

1.3 Research Objective

1.4 Assumptions & Limitations

1.5 Market Structure:

2 Research Methodology

2.1 Research Process

2.2 Primary Research

2.3 Secondary Research

3 Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges

3.5 Macroeconomic Indicators

4 Market Factor Analysis

4.1 Porter’s Five Forces Model

4.1.1 Bargaining Power Of Suppliers

4.1.2 Bargaining Power Of Customer

4.1.3 Intensity Of Competitor’s

4.1.4 Threat Of New Entrants

5 Global Sepsis Diagnostics Market, By Technology

…TOC Continued

List Of Tables

TABLE 1 GLOBAL SEPSIS DIAGNOSTICS MARKET, 2013-2022 (USD MILLION)

TABLE 2 GLOBAL SEPSIS DIAGNOSTICS MARKET, BY MATERIAL TYPE, 2013-2022 (USD MILLION)

TABLE 3 GLOBAL SEPSIS DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2013-2022 (USD MILLION)

TABLE 4 GLOBAL SEPSIS DIAGNOSTICS MARKET, BY END USERS, 2013-2022 (USD MILLION)

TABLE 5 GLOBAL SEPSIS DIAGNOSTICS MARKET, BY REGION, 2013-2022 (USD MILLION)

…Continued

List Of Figures

FIGURE 1 RESEARCH PROCESS

FIGURE 2 PORTERS FIVE FORCES MODEL

FIGURE 3 GLOBAL ORTHOPEDIC TRAUMA DEVICE SMARKET, BY MATERIAL TYPE

FIGURE 4 GLOBAL SEPSIS DIAGNOSTICS MARKET, BY PRODUCT TYPE

FIGURE 5 GLOBAL SEPSIS DIAGNOSTICS MARKET, BY END USERS

FIGURE 6 GLOBAL SEPSIS DIAGNOSTICS MARKET, BY REGION

FIGURE 7 GLOBAL SEPSIS DIAGNOSTICS MARKET: COMPANY SHARE ANALYSIS, 2015 (%)

…Continued

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/sepsis-diagnostics-market-2110

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Wednesday, 2 September 2020

Preclinical imaging Market 2019 - Shares, Revenue, Analysis And Forecasts Till 2023

Market Research Future With Their Unique Quality Of Simplifying The Market Research Study, Announces A Deep Study Report On “Preclinical imaging Market Research Report – Forecast To 2023” Gives Industry Size, Top Players And Worldwide Demand

Market Overview

Preclinical imaging is a research modality wherein small-animal models form the keystone for research and development strategies. They are a modern approach to solving health-related problems as they enable clinically transformable methods which help in monitoring the progression of various diseases. Market Research Future (MRFR)'s latest report on the global preclinical imaging market is a compilation of key market insights and discusses key market dynamics such as drivers, restraints, and opportunities at length. As per the analysis of MRFR, the preclinical imaging market is anticipated to expand at a CAGR of 6.3% over the forecast period of 2018-2023. The preclinical imaging market was valued at USD 2.01 Bn in 2017.

Also Read : https://www.globenewswire.com/news-release/2019/07/30/1893573/0/en/Preclinical-Imaging-Market-Will-Reflect-Significant-Growth-Prospects-of-6-3-CAGR-By-2023-Predicts-Market-Research-Future.html

Technological advancements in the field of molecular imaging, increasing market demand for non-invasive small-animal imaging techniques, and increasing funding to support preclinical researches are expected to drive the growth of preclinical imaging market. Many organization and foundation provide the funding support for the preclinical researche activity. The Alzheimer's Drug Discovery Foundation was providing the funding opportunity for preclinical study up to USD 5 million. Similarly, in 2015 Deutsches Zentrum für Herz-Kreislaufforschung e.V. (DZHK) offered Euro 6 million for the preclinical research projects. This funding supports the market growth.

Preclinical imaging has assumed a significant role in the drug development and discovery process, which is a key factor driving the market growth. Being a non-invasive technique, preclinical imaging has garnered many accolades from the healthcare industry. They offer various advantages over other imaging techniques. Preclinical imaging is relatively faster, accurate, and can be applied to lengthy and repetitive procedures. Preclinical imaging has found application across various healthcare fields such as neurology, cardiology, cancer research, cardiac imaging, functional and anatomical neuroimaging, and others. Technological advancements in the field of preclinical imaging which provide enhanced diagnosis of various disease conditions and aid research on complex experiments are likely to favor the growth of the market. Other factors which have promoted the growth of the preclinical imaging is surging awareness regarding the ill-effects aligned with radiation-based imaging.

Competitive Analysis

Bruker Corporation (US)
MR Solutions (UK)
PerkinElmer (US)
Fujifilm Holdings Corporation (Japan)
Milabs B.V. (The Netherlands)
Mediso Ltd. (Hungary)
Miltenyi Biotec GmbH (Germany)
LI-COR, Inc. (US)
Aspect Imaging (Israel)
Trifoil Imaging (US)

Segmentation

The preclinical imaging market has been segmented based on modality and reagent.

By modality, the preclinical imaging market has been segmented into optical imaging system, micro-CT, nuclear imaging system, micro-MRI, micro-ultrasound, photoacoustic imaging system, and magnetic particle imaging systems.

The optical imaging system segment has been further segmented into bioluminescence/fluorescence imaging systems, standalone fluorescence imaging system, and optical + X-ray/ optical + CT systems.

The nuclear imaging systems segment has been further segmented into micro-PET system, micro-spect system, and trimodality (Spect/PET/CT) system.

By reagent, the preclinical imaging market has been segmented preclinical nuclear imaging reagents, preclinical optical imaging reagents, preclinical MRI contrast agents, preclinical ultrasound contrast agents, and preclinical CT contrast agents. The preclinical optical imaging reagents segment has been further segmented into bioluminescent imaging reagents and fluorescent imaging reagents.

The preclinical nuclear imaging reagents segment has been further segmented into preclinical PET tracers and Preclinical Spect Probes.

Regional Analysis

Region-wise, the Preclinical Imaging Market has been segmented into the Americas, the Middle East & Africa (MEA), Europe, and Asia Pacific (APAC).

The global preclinical imaging market is dominated by North America on account of the presence of a robust healthcare infrastructure, technological advancements in the field of molecular imaging, and the presence of various market leaders in the region. Heightened demand for non-invasive small-animal imaging technique combined with increasing funding by the government to support preclinical imaging-based research are also promoting the growth of the market.

Europe is a major R&D hub with massive support from the governments in the form of R&D funds. Moreover, intensifying efforts by the governments to provide improved diagnostic services in the region is likely to spur the demand for preclinical imaging.

The APAC preclinical imaging market is anticipated to observe the fastest growth rate over the forecast period. Improving economic conditions and efforts to modernize the healthcare sector is speeding up the growth of the preclinical imaging market. The presence of a massive patient pool suffering from various chronic diseases is also boosting the demand for preclinical imaging.

The MEA preclinical imaging market is presumed to exhibit the least growth rate over the forecast period. The growth of the market is majorly cornered towards the Middle East, where countries such as UAE, Kuwait, and Saudi Arabia are investing heavily on the upgradation of the healthcare sector.

Intended Audience

Preclinical Imaging Manufacturers and vendors
Research organization and CRO
Various research and consulting firms

Industry Updates

July 2019 - Bruker, a manufacturer of scientific instruments for molecular and materials research, announced the acquisition of PMOD Technologies LLC, a research-use-only software provider for preclinical and molecular imaging.

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/preclinical-imaging-market-7365

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Global Nutrigenomics Market Positive Growth And Forecasts By 2023

Market Research Future With Their Unique Quality Of Simplifying The Market Research Study, Announces A Deep Study Report On “Nutrigenomics Market Research Report – Forecast To 2023” Gives Industry Size, Top Players And Worldwide Demand

Worldwide Nutrigenomics Market Overview

The latest data released by Market Research Future (MRFR) reveals that the Global Nutrigenomics Market will reach a valuation in excess of USD 17,313.5 Mn by the year 2023, reflecting an impressive growth rate. Much has been spoken about nutrigenomics in recent times, helping it gain ample commercial interest. Nutrigenomics is often viewed as an advanced field of research focused towards human genome, nutrition and health. Most companies specializing in nutrigenomics actively study and analyse the effects of food and their constituents on human genes to improve dietary patterns using specific products that are personalized based on an individual’s nutritional need. The nutrigenomics industry has quickly spurred as more start-ups join the bandwagon to capitalize on the arising opportunities. New entrances are indeed playing an important role in making the global nutrigenomics market more dynamic.

Also Read : https://www.globenewswire.com/news-release/2018/09/19/1572897/0/en/Nutrigenomics-Market-Size-17-313-5-Million-Poised-to-Witness-a-Sound-Growth-Over-2023-Market-Research-Future.html

Modern consumers, especially the millennial population have a greater level of health-awareness and willing to spend on products directed towards health, which encourages the nutrigenomics industry to make more efforts. Prevalence of chronic diseases has significantly increased in recent years prompting individuals to take preventive measures. This, in turn is reflected favorably on the global nutrigenomics market. Moreover, investments in nutrigenomics research & development programs have increased from both government and private entities. The aforementioned factors are providing an impetus to the market.

Nutrigenomics Market: Competition Tracking

Genomix Nutrition, Inc. (US), WellGen Inc. (US), NutraGene (India), Cura Integrative Medicine (Australia), Metagenics, Inc (US), XCODE Life Sciences Pvt. Ltd. (India), and Nutrigenomix (US) are some of the top companies operating in the global nutrigenomics market.

Industry News

Hong-Kong based genetic testing / digital health company Prenetics recently announced the acquisition of a U.K. based genetic information provider DNAFit. Reportedly, the acquisition saw Prenetics make a transaction of $10 million. The deal indicates towards Prenetics deep interest in consumer genomics space. The company has already established its business across Asia, providing test services for cancer, nutrigenomics, pharmacogenomics and reproductive health.

Leading healthcare company LifeVantage Corporation has reportedly worked on improving its market position in Asia by initiating new operation in Taiwan. The company is entering the Taiwan market with two of its popular skincare flagship brands Protandim Nrf2 Synergizer® and TrueScience® Beauty System.

Global Nutrigenomics Market Segmentation: Insights

MRFR’s data also includes a detailed segmental analysis of nutrigenomics market based on product, technique and application. By product, the market has been segment into services and reagents & kits. The latter will continue to outperform the former in 2018 and beyond. The reagents & kits segment is expected to surpass a market valuation of USD 10,130 Mn by 2023, reflecting a healthy growth rate. This is primarily owing to widespread usage of reagent and kits in nutrigenomics. By technique, the market is segmented into blood, buccal swab, saliva and others. By application, the Nutrigenomics Market is segmented into diabetes, obesity, anti-aging, and chronic diseases. The obesity segment currently commands for the highest share of the market and is expected to remain highly attractive. The diabetes segment is also expected catch momentum in the forthcoming years. The segment is projected to capture a robust CAGR of 17.1% during the assessment period (2017-2023).

North America at the Forefront of the Global Nutrigenomics Market

Of the four regions (Americas, Europe, Asia Pacific, and the Middle East & Africa) that have been included in MRFR’s data, Americas has been marked as an extremely important market for nutrigenomics. Towards the end of 2023, the region’s market is likely to touch a valuation of more than USD 6,300 Mn. Increased prevalence of lifestyle diseases in countries such as the U.S., Canada, Mexico and Brazil has fuelled the demand for personalized medication and nutrient-rich food items. The nutrigenomics industry is witnessing an upward trend in several countries in the region. Americas is followed by Europe, the market in Europe is expected to exhibit a steady growth over the next couple of years. Advanced economies in the region accounts for a relatively higher market share. This can be attributed to the presence of a state-of-the-art healthcare system in these countries. In addition, a large number of Europeans have a high healthcare expenditure. The market in Europe is expected to surge at 17% CAGR during the assessment period. Meanwhile, Asia Pacific (APAC) is also expected to emerge as a fast-growing market for nutrigenomics over 2023. China and India are viewed a massive consumer market as these countries continue to improve their economic growth. As a result, per capita income has leapfrogged in these countries along with higher health awareness, which is supporting the growth of the market in the region. APAC nutrigenomics market is set witness a 17.1% CAGR during the review period.

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/nutrigenomics-market-4009

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Liquid Biopsy Market Worldwide Key Players Forecasts By Revenue, Growth Rate Till 2023

Market Research Future With Their Unique Quality Of Simplifying The Market Research Study, Announces A Deep Study Report On “Liquid Biopsy Market Research Report – Forecast To 2023” Gives Industry Size, Top Players And Worldwide Demand

The International Liquid Biopsy Market Report immensely promising is not without its challenges, and market growth is anticipated to be hindered by the prohibitive costs which are associated with liquid biopsy. Moreover, prostate and brain cancer may lie dormant for years, and patients may not benefit from early detection in such cases. Lack of awareness and a dearth of well-trained professionals in developing regions are some other challenges posed to the global liquid biopsy market. However, growing collaborations between companies and increased funding from public organizations are expected to open up the market for new entrants and provide ample opportunity. The unmet needs in emerging markets represent massive potential for growth in the foreseeable future.

Market Research Future has released its extensively detailed report on the Global Liquid Biopsy Market which is anticipated to grow at a noteworthy CAGR of 28% during the forecast period which ends in 2022. Largely non-invasive, liquid biopsy offers diagnostic capabilities and represents advancement in human genome sequencing. Valued at USD 3950 Mn at the start of the forecast period, the market is on track to reach an estimated evaluation of USD 17,372.28 Mn by 2023.

Also Read : https://www.globenewswire.com/news-release/2018/08/28/1557722/0/en/Liquid-Biopsy-Market-Size-Expected-to-Touch-USD-17-372-28-Mn-by-2023-Recent-Trends-and-Technologies-in-Medical-Device-Industry.html

The healthcare sector is expanding at a rapid pace, and novel methods of diagnostics have arisen with the increased demand for minimally or non-invasive diagnostic tests. Rising occurrences of cancer and other chronic diseases have increased the demand for accurate diagnostics. Liquid biopsy is painless and non-invasive, particularly when compared to other diagnostic tests. Moreover, liquid biopsy offers real-time detection of diseases with high precision. Other factors driving the global liquid biopsy market are lifestyle changes which lead to increased cancer diagnoses, rising investments in research & development activities, rising geriatric population and the growing expenditure on healthcare. Liquid biopsy carries significant potential for use in diagnoses of cardiovascular diseases and autoimmune diseases.

Key Players

MRFR has scoped the competitive landscape of the market to reveal various market strategies utilized by leading market players to strengthen their market position. Research & development activities, collaborations, and acquisitions & mergers are some of the most effective strategies being implemented by prominent market players which include Circulogene Theranostics, Exosome Diagnostics, Guardant Health Inc., Agena Bioscience Inc., SAGA Diagnostics AB, RainDance Technologies Inc., Admera Health, Inivata Ltd., Biocept, Inc., Trovagene Inc., and others.

Latest Industry News

MDNA Life Sciences has just announced its exclusive licensing agreement with the Laboratory Corporation of America for a non-invasive liquid biopsy test for the diagnosis of prostate cancer.
Angle plc has announced that its Parsortix system has demonstrated the ability to detect circulating tumor cells (CTCs) in human glioblastoma.

Liquid Biopsy Market Segmentation

MRFR's analysis of the Liquid Biopsy Market segments it on the basis of various pertinent factors which allow detailed insight into the various facets of the global liquid biopsy market. Segmentation of the global liquid biopsy market has been performed on the basis of biomarker types, application, sample, end-user, and region. By biomarker types, the market is segmented to include extracellular vehicles (EVs), circulating tumor DNA (CtDNA), circulating tumor cells (CTCs) and other biomarkers. Other biomarkers include circulating RNA and proteins. The circulating tumor cells (CTC) segment dominates the market in terms of revenue as represented by its 55.48% share. The advancements done for this type of biomarker and its extensive use in diagnostics are responsible for its market position.

By application, the Liquid Biopsy Market is segmented into reproductive health, cancer, and other therapeutic applications. The cancer segment is the largest segment with the highest share of the market due to the rising demand for minimally invasive and accurate tests for cancer diagnoses.

By sample, the market is segmented into urine sample, blood sample, and other sample. The blood sample segment accounts for the most significant segment. However, the urine sample segment is expected to witness considerable growth over the assessment period.

By end-user, the market is categorized into academic & research centers, and other end users.

The global division of the market for analysis includes North America, Europe, Asia Pacific and the Middle East and Africa.

Unmet Potential Translates to Highest Growth for APAC Region

The Global Liquid Biopsy Market is led by North America which presently accounts for more than one-third of the market. The region has a high concentration of leading market players who are actively participating and contributing to market growth. With a valuation of USD 1,499.10 mn at the start of the forecast period, the regional market is set to grow exponentially. North America is closely followed by Europe due to the similar growth pattern these regions share. Both regions have public bodies who are funding investments in an effort to reduce development costs which will ultimately benefit the global market. A high geriatric population, well-established healthcare sector and high adoption rate of advanced medical processes are some other drivers which impact the growth of these regions positively.

Meanwhile, growing at an impressive CAGR of 28.8%, the Asia Pacific is anticipated to witness the fastest growth among all regions recorded in the report. The region has a high concentration of rapidly emerging markets which are undergoing urbanization and have resulted in huge lifestyle changes, thus leading to increased occurrences of chronic diseases. The presence of a large patient population has been recognized by global market players, and the region is rapidly working toward adopting advanced healthcare practices and revamping existing facilities to meet the growing need for the effective diagnostic test. Unmet needs in this region represent huge potential for future growth.

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/liquid-biopsy-market-710

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com